Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
CancerChild healthComputers and information technologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth technology, devices, suppliesMedical researchResearch administration and fundingResearch and development
Childhood Cancer STAR Reauthorization Act
USA117th CongressS-4120| Senate
| Updated: 1/5/2023
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
CancerChild healthComputers and information technologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth technology, devices, suppliesMedical researchResearch administration and fundingResearch and development